National Wilm's Tumor Study Late Effects
The Late Effects Study is being conducted in order to answer scientific questions and to
serve as a resource for Wilms tumor patients and their families. Although most people in
this study enjoy good health, some may be at risk for certain health conditions. We are
collecting information from as many participants as possible in order to determine if they
or their offspring are at risk for adverse medical conditions. If there is more than one
case of Wilms tumor in a given family, we plan to work with geneticists to try to estimate
heritability and recurrence risks.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening
To determine if survivors from Wilms tumors or their offspring are at risk for adverse medical conditions.
1 year after closure of study
Howard Katzenstein, MD
Children's Healthcare of Atlanta
United States: Food and Drug Administration
|Children's Healthcare of Atlanta||Atlanta, Georgia 30342|